The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Nanomedicine and Nanobiotechnology-Global Market Insights and Sales Trends 2025
Synopsis
The global Nanomedicine and Nanobiotechnology market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Nanomedicine and Nanobiotechnology in various end use industries. The expanding demands from the Hospitals, Clinics and Research Institute,, are propelling Nanomedicine and Nanobiotechnology market. Nanoparticles, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Nanoshells segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Nanomedicine and Nanobiotechnology, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Nanomedicine and Nanobiotechnology market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Nanomedicine and Nanobiotechnology market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Nanomedicine and Nanobiotechnology sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Nanomedicine and Nanobiotechnology covered in this report include Abbott, GE Healthcare, Johnson & Johnson, Merck, Pfizer, CombiMatrix, Celgene, Mallinckrodt and Sigma-Tau Pharmaceuticals, etc.
The global Nanomedicine and Nanobiotechnology market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott
GE Healthcare
Johnson & Johnson
Merck
Pfizer
CombiMatrix
Celgene
Mallinckrodt
Sigma-Tau Pharmaceuticals
Teva Pharmaceutical
Nanosphere
UCB SA
Global Nanomedicine and Nanobiotechnology market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Nanomedicine and Nanobiotechnology market, Segment by Type:
Nanoparticles
Nanoshells
Nanotubes
Nanodevices
Others
Global Nanomedicine and Nanobiotechnology market, by Application
Hospitals
Clinics
Research Institute
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Nanomedicine and Nanobiotechnology companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Nanomedicine and Nanobiotechnology market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Nanomedicine and Nanobiotechnology in various end use industries. The expanding demands from the Hospitals, Clinics and Research Institute,, are propelling Nanomedicine and Nanobiotechnology market. Nanoparticles, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Nanoshells segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Nanomedicine and Nanobiotechnology, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Nanomedicine and Nanobiotechnology market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Nanomedicine and Nanobiotechnology market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Nanomedicine and Nanobiotechnology sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Nanomedicine and Nanobiotechnology covered in this report include Abbott, GE Healthcare, Johnson & Johnson, Merck, Pfizer, CombiMatrix, Celgene, Mallinckrodt and Sigma-Tau Pharmaceuticals, etc.
The global Nanomedicine and Nanobiotechnology market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott
GE Healthcare
Johnson & Johnson
Merck
Pfizer
CombiMatrix
Celgene
Mallinckrodt
Sigma-Tau Pharmaceuticals
Teva Pharmaceutical
Nanosphere
UCB SA
Global Nanomedicine and Nanobiotechnology market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Nanomedicine and Nanobiotechnology market, Segment by Type:
Nanoparticles
Nanoshells
Nanotubes
Nanodevices
Others
Global Nanomedicine and Nanobiotechnology market, by Application
Hospitals
Clinics
Research Institute
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Nanomedicine and Nanobiotechnology companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Nanomedicine and Nanobiotechnology
1.1 Nanomedicine and Nanobiotechnology Market Overview
1.1.1 Nanomedicine and Nanobiotechnology Product Scope
1.1.2 Nanomedicine and Nanobiotechnology Market Status and Outlook
1.2 Global Nanomedicine and Nanobiotechnology Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Nanomedicine and Nanobiotechnology Market Size by Region (2018-2029)
1.4 Global Nanomedicine and Nanobiotechnology Historic Market Size by Region (2018-2023)
1.5 Global Nanomedicine and Nanobiotechnology Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Nanomedicine and Nanobiotechnology Market Size (2018-2029)
1.6.1 North America Nanomedicine and Nanobiotechnology Market Size (2018-2029)
1.6.2 Europe Nanomedicine and Nanobiotechnology Market Size (2018-2029)
1.6.3 Asia-Pacific Nanomedicine and Nanobiotechnology Market Size (2018-2029)
1.6.4 Latin America Nanomedicine and Nanobiotechnology Market Size (2018-2029)
1.6.5 Middle East & Africa Nanomedicine and Nanobiotechnology Market Size (2018-2029)
2 Nanomedicine and Nanobiotechnology Market by Type
2.1 Introduction
2.1.1 Nanoparticles
2.1.2 Nanoshells
2.1.3 Nanotubes
2.1.4 Nanodevices
2.1.5 Others
2.2 Global Nanomedicine and Nanobiotechnology Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Nanomedicine and Nanobiotechnology Historic Market Size by Type (2018-2023)
2.2.2 Global Nanomedicine and Nanobiotechnology Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Nanomedicine and Nanobiotechnology Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Nanomedicine and Nanobiotechnology Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Nanomedicine and Nanobiotechnology Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Nanomedicine and Nanobiotechnology Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Nanomedicine and Nanobiotechnology Revenue Breakdown by Type (2018-2029)
3 Nanomedicine and Nanobiotechnology Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Research Institute
3.2 Global Nanomedicine and Nanobiotechnology Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Nanomedicine and Nanobiotechnology Historic Market Size by Application (2018-2023)
3.2.2 Global Nanomedicine and Nanobiotechnology Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Nanomedicine and Nanobiotechnology Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Nanomedicine and Nanobiotechnology Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Nanomedicine and Nanobiotechnology Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Nanomedicine and Nanobiotechnology Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Nanomedicine and Nanobiotechnology Revenue Breakdown by Application (2018-2029)
4 Nanomedicine and Nanobiotechnology Competition Analysis by Players
4.1 Global Nanomedicine and Nanobiotechnology Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nanomedicine and Nanobiotechnology as of 2022)
4.3 Date of Key Players Enter into Nanomedicine and Nanobiotechnology Market
4.4 Global Top Players Nanomedicine and Nanobiotechnology Headquarters and Area Served
4.5 Key Players Nanomedicine and Nanobiotechnology Product Solution and Service
4.6 Competitive Status
4.6.1 Nanomedicine and Nanobiotechnology Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott
5.1.1 Abbott Profile
5.1.2 Abbott Main Business
5.1.3 Abbott Nanomedicine and Nanobiotechnology Products, Services and Solutions
5.1.4 Abbott Nanomedicine and Nanobiotechnology Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Recent Developments
5.2 GE Healthcare
5.2.1 GE Healthcare Profile
5.2.2 GE Healthcare Main Business
5.2.3 GE Healthcare Nanomedicine and Nanobiotechnology Products, Services and Solutions
5.2.4 GE Healthcare Nanomedicine and Nanobiotechnology Revenue (US$ Million) & (2018-2023)
5.2.5 GE Healthcare Recent Developments
5.3 Johnson & Johnson
5.3.1 Johnson & Johnson Profile
5.3.2 Johnson & Johnson Main Business
5.3.3 Johnson & Johnson Nanomedicine and Nanobiotechnology Products, Services and Solutions
5.3.4 Johnson & Johnson Nanomedicine and Nanobiotechnology Revenue (US$ Million) & (2018-2023)
5.3.5 Merck Recent Developments
5.4 Merck
5.4.1 Merck Profile
5.4.2 Merck Main Business
5.4.3 Merck Nanomedicine and Nanobiotechnology Products, Services and Solutions
5.4.4 Merck Nanomedicine and Nanobiotechnology Revenue (US$ Million) & (2018-2023)
5.4.5 Merck Recent Developments
5.5 Pfizer
5.5.1 Pfizer Profile
5.5.2 Pfizer Main Business
5.5.3 Pfizer Nanomedicine and Nanobiotechnology Products, Services and Solutions
5.5.4 Pfizer Nanomedicine and Nanobiotechnology Revenue (US$ Million) & (2018-2023)
5.5.5 Pfizer Recent Developments
5.6 CombiMatrix
5.6.1 CombiMatrix Profile
5.6.2 CombiMatrix Main Business
5.6.3 CombiMatrix Nanomedicine and Nanobiotechnology Products, Services and Solutions
5.6.4 CombiMatrix Nanomedicine and Nanobiotechnology Revenue (US$ Million) & (2018-2023)
5.6.5 CombiMatrix Recent Developments
5.7 Celgene
5.7.1 Celgene Profile
5.7.2 Celgene Main Business
5.7.3 Celgene Nanomedicine and Nanobiotechnology Products, Services and Solutions
5.7.4 Celgene Nanomedicine and Nanobiotechnology Revenue (US$ Million) & (2018-2023)
5.7.5 Celgene Recent Developments
5.8 Mallinckrodt
5.8.1 Mallinckrodt Profile
5.8.2 Mallinckrodt Main Business
5.8.3 Mallinckrodt Nanomedicine and Nanobiotechnology Products, Services and Solutions
5.8.4 Mallinckrodt Nanomedicine and Nanobiotechnology Revenue (US$ Million) & (2018-2023)
5.8.5 Mallinckrodt Recent Developments
5.9 Sigma-Tau Pharmaceuticals
5.9.1 Sigma-Tau Pharmaceuticals Profile
5.9.2 Sigma-Tau Pharmaceuticals Main Business
5.9.3 Sigma-Tau Pharmaceuticals Nanomedicine and Nanobiotechnology Products, Services and Solutions
5.9.4 Sigma-Tau Pharmaceuticals Nanomedicine and Nanobiotechnology Revenue (US$ Million) & (2018-2023)
5.9.5 Sigma-Tau Pharmaceuticals Recent Developments
5.10 Teva Pharmaceutical
5.10.1 Teva Pharmaceutical Profile
5.10.2 Teva Pharmaceutical Main Business
5.10.3 Teva Pharmaceutical Nanomedicine and Nanobiotechnology Products, Services and Solutions
5.10.4 Teva Pharmaceutical Nanomedicine and Nanobiotechnology Revenue (US$ Million) & (2018-2023)
5.10.5 Teva Pharmaceutical Recent Developments
5.11 Nanosphere
5.11.1 Nanosphere Profile
5.11.2 Nanosphere Main Business
5.11.3 Nanosphere Nanomedicine and Nanobiotechnology Products, Services and Solutions
5.11.4 Nanosphere Nanomedicine and Nanobiotechnology Revenue (US$ Million) & (2018-2023)
5.11.5 Nanosphere Recent Developments
5.12 UCB SA
5.12.1 UCB SA Profile
5.12.2 UCB SA Main Business
5.12.3 UCB SA Nanomedicine and Nanobiotechnology Products, Services and Solutions
5.12.4 UCB SA Nanomedicine and Nanobiotechnology Revenue (US$ Million) & (2018-2023)
5.12.5 UCB SA Recent Developments
6 North America
6.1 North America Nanomedicine and Nanobiotechnology Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Nanomedicine and Nanobiotechnology Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Nanomedicine and Nanobiotechnology Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Nanomedicine and Nanobiotechnology Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Nanomedicine and Nanobiotechnology Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Nanomedicine and Nanobiotechnology Market Dynamics
11.1 Nanomedicine and Nanobiotechnology Industry Trends
11.2 Nanomedicine and Nanobiotechnology Market Drivers
11.3 Nanomedicine and Nanobiotechnology Market Challenges
11.4 Nanomedicine and Nanobiotechnology Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
